ArticleActa pharmacologica Sinica2024

A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis.

Wei-Zhi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.